Mutation as a Toxicological Endpoint for Regulatory Decision-Making

Area of Science:

• Toxicology
• Genetics
• Molecular Biology

Background:

• Mutations in somatic and germ cells cause human diseases.
• Mutation per se has been recognized as an adverse health concern since the early 20th century.
• Regulatory agencies commonly use in vitro and in vivo somatic cell mutation data for hazard identification.

Purpose of the Study:

• To highlight the increasing use of quantitative mutagenicity dose-response data in risk assessments.
• To emphasize the ongoing efforts to improve mutation measurement and computational evaluation methods.
• To recommend continued development of these approaches for comprehensive toxicological risk assessments.

Main Methods:

• Review of current practices in mutation data analysis.
• Discussion of ongoing advancements in mutation measurement techniques.
• Exploration of refined computational methods for evaluating mutation data.

Main Results:

• Quantitative mutagenicity dose-response data are increasingly utilized for risk assessments.
• Development is progressing in both mutation measurement and computational evaluation.
• There is a need for consensus on including quantitative mutation analysis in toxicological risk assessments.

Conclusions:

• Continued development of mutation analysis methods is recommended.
• Establishing consensus on quantitative mutation analysis as a required endpoint is crucial.
• This approach will enhance comprehensive toxicological risk assessments for human health.